Tumor induction by a single subcutaneous injection of 1-butyl-1-nitrosourea or 1-butylurea in newborn mice.
K Fujii, K Nomoto
Index: Cancer Lett. 18(3) , 321-8, (1983)
Full Text: HTML
Abstract
A subcutaneous injection of 1-butyl-1-nitrosourea (BNU) at the maximum tolerated dose (333 mg/kg body wt.) to newborn CDF1 mice induced adenocarcinoma and adenoma of the lung, adenoma of the liver, thymic or non-thymic lymphoma and neurinoma of the acusticus nerve; the total incidence of tumors was statistically significant as compared with that of control. However, in the 1-butylurea (BU) mice, one adenoma of the lung was induced in a male mouse; the total incidence of tumor was comparable to that of control.
Related Compounds
Related Articles:
A quadruply hydrogen bonded heterocomplex displaying high-fidelity recognition.
2005-12-28
[J. Am. Chem. Soc. 127(51) , 18133-42, (2005)]
Comparative evaluation of fifteen anti-sickling agents.
1983-04-01
[Blood 61(4) , 693-704, (1983)]
Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease.
2003-11-03
[Bioorg. Med. Chem. 11(22) , 4769-77, (2003)]
Inhibition of HIV-1 infection by alkylureas.
1991-12-01
[AIDS 5(12) , 1447-52, (1991)]
2004-06-02
[J. Am. Chem. Soc. 126(21) , 6522-3, (2004)]